Pharmacy Seminar to Focus on New Vaccines
"Technologies for the Discovery of New Vaccines" is the next event in the James L. Winkle College of Pharmacy's Seminars in Drug Development Series. The presenter is Jeff Ulmer, PhD, global head of external research and development at Novartis Vaccines & Diagnostics, Inc.
The seminar is scheduled for 5 to 6 p.m. Monday, Nov. 19, in Room 231 of the Health Professions Building. A reception honoring Ulmer will follow the seminar. Following the reception, Ulmer will conduct an interactive lecture titled, "Challenges in the Development of Vaccines."
The seminar is hosted by the MS in Pharmaceutical Sciences with Drug Development Track and the UC Student Chapter of American Association of Pharmaceutical Scientists (AAPS).
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.